<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04323683</url>
  </required_header>
  <id_info>
    <org_study_id>13/EM/0277</org_study_id>
    <nct_id>NCT04323683</nct_id>
  </id_info>
  <brief_title>The Effect of Progesterone on Human Endometrium</brief_title>
  <official_title>The Effect of Progesterone Levels on Human Endometrial Transcriptomics During the Implantation Window</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the relationship between progesterone levels and endometrial gene
      expression
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differentially expressed genes between women with low and normal progesterone</measure>
    <time_frame>2 months</time_frame>
    <description>Fold-change and p-value were used to determine differentially expressed genes using Partek software</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Fertility</condition>
  <arm_group>
    <arm_group_label>Low progesterone</arm_group_label>
    <description>Women with progesterone level below 15 ng/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal progesterone</arm_group_label>
    <description>Women with progesterone level above 15 ng/ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Microarray</intervention_name>
    <description>High throughput technique for determining global gene expression of the condition of interest</description>
    <arm_group_label>Low progesterone</arm_group_label>
    <arm_group_label>Normal progesterone</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA obtained from endometrium
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Fertile women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-35, regular menstrual cycles, the cycle length between 25 and 35 days, body
             mass index (BMI) between 18 - 25

        Exclusion Criteria:

          -  History of infertility, history of pelvic pain or/and endometriosis, history of pelvic
             mass, history of hormonal therapy in the last 3 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Queen's medical center</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nottingham</investigator_affiliation>
    <investigator_full_name>Walid Maalouf</investigator_full_name>
    <investigator_title>Course Director MMedSci Assisted Reproduction Technology, Faculty of Medicine &amp; Health Sciences</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

